The Irish Competition Authority clears acquisition of a pharmaceutical retail chain's parent company by its rival subject to commitments (Uniphar / LXV Remedies)

Competition Authority, Irish

Previous article The US FTC announces 2023 update on size of transaction thresholds for premerger notification filings and Interlocking directorates Next article The Australian Competition Authority consults on a proposed court-enforceable divestiture by a supplier of construction chemicals in its acquisition of a rival (Sika / MBCC)

20 Jan 2023

The Irish Competition Authority clears acquisition of a pharmaceutical retail chain’s parent company by its rival subject to commitments (Uniphar / LXV Remedies)

KEYWORDS

Reference

Irish Competition Authority, Uniphar / LXV Remedies, Press release, 20 January 2023

CCPC requires binding commitments from Uniphar to acquire Sam McCauley Chemists* The Competition and Consumer Protection Commission (CCPC) has cleared, subject to a number of legally binding commitments, the proposed acquisition by Uniphar PLC (Uniphar) of sole control of LXV Remedies (M/22/049). LXV Remedies is the parent company of Sam McCauley Chemists Limited (Sam

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Irish Competition Authority
Irish Competition Authority (Dublin)

Ireland 86 contributions 13984 visits

Quotation

Irish Competition Authority, The Irish Competition Authority clears acquisition of a pharmaceutical retail chain’s parent company by its rival subject to commitments (Uniphar / LXV Remedies), 20 January 2023, e-Competitions January 2023 - II, Art. N° 110682

Visites 37